Belpointe Asset Management LLC Invests $40,000 in Utah Medical Products, Inc. (NASDAQ:UTMD)

Belpointe Asset Management LLC acquired a new position in Utah Medical Products, Inc. (NASDAQ:UTMD – Get Rating) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 400 shares of the medical instruments supplier’s stock, valued at approximately $40,000.

A number of other institutional investors have also made changes to their positions in UTMD. Acadian Asset Management LLC bought a new position in Utah Medical Products during the first quarter valued at about $40,000. BNP Paribas Arbitrage SA increased its stake in Utah Medical Products by 97.7% during the second quarter. BNP Paribas Arbitrage SA now owns 779 shares of the medical instruments supplier’s stock valued at $67,000 after acquiring an additional 385 shares during the period. Lazard Asset Management LLC increased its stake in Utah Medical Products by 21.3% during the first quarter. Lazard Asset Management LLC now owns 837 shares of the medical instruments supplier’s stock valued at $75,000 after acquiring an additional 147 shares during the period. BNP Paribas Arbitrage SNC increased its stake in Utah Medical Products by 33.5% during the third quarter. BNP Paribas Arbitrage SNC now owns 1,040 shares of the medical instruments supplier’s stock valued at $89,000 after acquiring an additional 261 shares during the period. Finally, MetLife Investment Management LLC increased its stake in Utah Medical Products by 57.0% during the first quarter. MetLife Investment Management LLC now owns 2,030 shares of the medical instruments supplier’s stock valued at $182,000 after acquiring an additional 737 shares during the period. 70.04% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Utah Medical Products news, Director Paul O. Richins sold 700 shares of the company’s stock in a transaction on Thursday, May 18th. The stock was sold at an average price of $93.47, for a total transaction of $65,429.00. Following the transaction, the director now owns 21,461 shares of the company’s stock, valued at approximately $2,005,959.67. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 6.50% of the company’s stock.

Utah Medical Products Price Performance

Shares of UTMD opened at $93.49 on Friday. The company has a market capitalization of $339.37 million, a P/E ratio of 19.85 and a beta of 0.19. Utah Medical Products, Inc. has a one year low of $80.10 and a one year high of $109.50. The business’s 50 day simple moving average is $93.77 and its 200-day simple moving average is $93.00.

Utah Medical Products Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 6th. Shareholders of record on Friday, June 16th will be issued a dividend of $0.295 per share. This represents a $1.18 annualized dividend and a yield of 1.26%. The ex-dividend date of this dividend is Thursday, June 15th. Utah Medical Products’s dividend payout ratio is 25.05%.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on Utah Medical Products in a research note on Thursday, May 18th. They set a “strong-buy” rating on the stock.

Utah Medical Products Company Profile

(Get Rating)

Utah Medical Products, Inc engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology.